Literature DB >> 28603836

Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study.

Shane Darke1, Sharlene Kaye1,2, Johan Duflou1,3.   

Abstract

AIMS: To (1) assess trends in the number and mortality rates of methamphetamine-related death in Australia, 2009-15; (2) assess the characteristics and the cause, manner and circumstances of death; and (3) assess the blood methamphetamine concentrations and the presence of other drugs in methamphetamine-related death.
DESIGN: Analysis of cases of methamphetamine-related death retrieved from the National Coronial Information System (NCIS).
SETTING: Australia. CASES: All cases in which methamphetamine was coded in the NCIS database as a mechanism contributing to death (n = 1649). MEASUREMENTS: Information was collected on cause and manner of death, demographics, location, circumstances of death and toxicology.
FINDINGS: The mean age of cases was 36.9 years, and 78.4% were male. The crude mortality rate was 1.03 per 100 000. The rate increased significantly over time (P < 0.001), and at 2015 the mortality rate was 1.8 [confidence interval (CI) = 1.2-2.4] times that of 2009. Deaths were due to accidental drug toxicity (43.2%), natural disease (22.3%), suicide (18.2%), other accident (14.9%) and homicide (1.5%). In 40.8% of cases, death occurred outside the major capital cities. The median blood methamphetamine concentration was 0.17 mg/l, and cases in which only methamphetamine was detected had higher concentrations than other cases (0.30 versus 0.15 mg/l, P < 0.001). The median blood methamphetamine concentration varied within a narrow range (0.15-0.20 mg/l) across manner of death. In the majority (82.8%) of cases, substances other than methamphetamine were detected, most frequently opioids (43.1%) and hypnosedatives (38.0%).
CONCLUSIONS: Methamphetamine death rates doubled in Australia from 2009 to 2015. While toxicity was the most frequent cause, natural disease, suicide and accident comprised more than half of deaths.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  Circumstances; disease; epidemiology; methamphetamine; mortality; toxicity

Mesh:

Substances:

Year:  2017        PMID: 28603836     DOI: 10.1111/add.13897

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  18 in total

1.  Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern U.S. City.

Authors:  Raminta Daniulaityte; Sydney M Silverstein; Timothy N Crawford; Silvia S Martins; William Zule; Angela J Zaragoza; Robert G Carlson
Journal:  Subst Use Misuse       Date:  2020-05-22       Impact factor: 2.164

2.  Optogenetic inhibition of the medial prefrontal cortex reduces methamphetamine-primed reinstatement in male and female rats.

Authors:  Rebecca Cordie; Lisa M McFadden
Journal:  Behav Pharmacol       Date:  2019-09       Impact factor: 2.293

Review 3.  Methamphetamine Use and Cardiovascular Disease.

Authors:  Christopher G Kevil; Nicholas E Goeders; Matthew D Woolard; Md Shenuarin Bhuiyan; Paari Dominic; Gopi K Kolluru; Connie L Arnold; James G Traylor; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

4.  Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008-2017.

Authors:  Christopher M Jones; Emily O Olsen; Julie O'Donnell; Desiree Mustaquim
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

Review 5.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

6.  Adverse childhood experiences and stimulant use disorders among adults in the United States.

Authors:  Shichao Tang; Christopher M Jones; April Wisdom; Hsien-Chang Lin; Sarah Bacon; Debra Houry
Journal:  Psychiatry Res       Date:  2021-03-13       Impact factor: 3.222

Review 7.  Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.

Authors:  Christopher M Jones; Debra Houry; Beth Han; Grant Baldwin; Alana Vivolo-Kantor; Wilson M Compton
Journal:  Ann N Y Acad Sci       Date:  2021-09-24       Impact factor: 6.499

8.  Event-level patterns of methamphetamine and poly-drug use among millennial sexual minority men: The P18 Cohort Study.

Authors:  Richard J Martino; Stephanie Shiau; Kristen D Krause; Perry N Halkitis
Journal:  Addict Behav       Date:  2021-01-19       Impact factor: 4.591

Review 9.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

10.  Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17.

Authors:  Christopher M Jones; Natasha Underwood; Wilson M Compton
Journal:  Addiction       Date:  2019-10-24       Impact factor: 7.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.